Cardiologist Catherine Gebhard’s research focuses on why certain diseases affect women and men differently. For the gender medicine pioneer, the corona pandemic is both a textbook example and a call for action at the same time.
In a study financed by the Swiss National Science Foundation, Catherine Gebhard and colleagues are investigated the influence of sex and gender on the course of Covid-19 disease. “We assume that it is the impact of gender hormones on particular cell molecules and the differing immune responses between women and men that are chiefly responsible,” says Gebhard.
The University Hospital Zurich (USZ) as well as university clinics in Basel, Bern and Berlin are involved in the work. It is hoped, the researcher says, that initial results will be ready by the end of the year. The same goes for outcomes on the immune system from studies looking at gender-specific responses to inflammatory reactions.